Webinar Recording
A Combination Treatment for Patients with Advanced Renal Cell Carcinoma
Recorded on: March 5, 2025
How can clinicians maximize the efficacy of cabozantinib in combination therapy for advanced renal cell carcinoma while minimizing toxicity?
Jennifer Hasiak, PharmD, breaks down the latest data on cabozantinib combinations, discusses strategies to mitigate adverse effects, and highlights key resources to support both clinicians and patients.
Send your feedback
Please do not include any personal information or details.
"*" indicates required fields
Was this page
helpful?
Send your feedback
Please do not include any personal information or details.
"*" indicates required fields